Home
About
Overview
Sharing Data
ORCID
Help
History (30)
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Undertreatment of Gallbladder Cancer: A Nationwide Analysis.
Variation in opioid prescribing patterns between ED providers.
Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral ?d cells.
Acute emesis: moderately emetogenic chemotherapy.
See All 30 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Acute emesis: moderately emetogenic chemotherapy.
Herrstedt J, Rapoport B, Warr D, Roila F, Bria E, Rittenberg C, Hesketh PJ. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer. 2011 Mar; 19 Suppl 1:S15-23.
View in:
PubMed
subject areas
Antiemetics
Antineoplastic Agents
Dose-Response Relationship, Drug
Drug Administration Schedule
Glucocorticoids
Humans
Neurokinin-1 Receptor Antagonists
Serotonin Antagonists
Vomiting
authors with profiles
Paul Joseph Hesketh MD